McCormick Q3 adjusted EPS $0.85 (+2.4% YoY); cuts FY2025 profit outlook on tariffs, commodity costs

MCCORMICK & CO INC

2025-Q3 EPS reported $2.09 revenue$4,989,900,000

Net sales +3% to $1.725B; organic +2% volume-led; Consumer segment net sales +4% to $973M.
Adjusted EPS $0.85 vs $0.83 YoY; GAAP EPS $0.84.
Gross margin contracted 130 bps to 37.4% due to higher commodity costs and tariffs.
FY2025 adjusted EPS guidance lowered to $3.00-$3.05 from $3.03-$3.08; adj. op. income growth now 2-4% (was 3-5%).
Expects $20M in special charges; tax rate ~22% vs 20.5% in 2024; high-single-digit decline in unconsolidated ops income.

item 2.02 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0000063754-25-000063
form_type: 8-K
ticker: MKC
cik: 0000063754
company_name: MCCORMICK & CO INC
filed_at: 2025-10-07T23:59:59+00:00
discovered_at: 2026-05-14T18:02:41.897661+00:00
generated_at: 2026-05-17T04:31:20.545887+00:00
sec_items: ["2.02", "9.01"]
event_type: earnings
sentiment: negative
materiality_score: 0.7
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0000063754-25-000063
json_url: https://secwatch.observer/filing/0000063754-25-000063.json
markdown_url: https://secwatch.observer/filing/0000063754-25-000063.md
text_url: https://secwatch.observer/filing/0000063754-25-000063.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/63754/000006375425000063/0000063754-25-000063-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/63754/000006375425000063/mkc-20251007.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0000063754-25-000063

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.